Age: 60.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Hypoaesthesia, Muscle spasms, Musculoskeletal discomfort, Myalgia, Pyrexia
Clinical narrative: Then her back went numb, with a lump/a numb feeling in the right side of my spine; pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine "; fever; joint pain; muscle pain/aching all; fatigue; urinary incontinence/pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine "; flank pain; a weird spasm in that area; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain/aching all), FATIGUE (fatigue) and URINARY INCONTINENCE (urinary incontinence/pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine ") in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 074B22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products GLUCOSAMINE SULFATE (FLEXTRIL) for an unknown indication and KETOROLAC TROMETHAMINE (TORADOL) for an unknown indication.    Previously administered products included for Drug use for unknown indication: Influenza vaccine. Past adverse reactions to the above products included No adverse event with Influenza vaccine. Concomitant products included INFLUENZA VACCINE (INFLUENZA) for an unknown indication.   On 07-Nov-2022 at 6:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started GLUCOSAMINE SULFATE (FLEXTRIL) (unknown route) at an unspecified dose and KETOROLAC TROMETHAMINE (TORADOL) (unknown route) at an unspecified dose. On 07-Nov-2022, the patient experienced PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain/aching all), FATIGUE (fatigue), URINARY INCONTINENCE (urinary incontinence/pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine "), FLANK PAIN (flank pain) and MUSCLE SPASMS (a weird spasm in that area). On an unknown date, the patient experienced HYPOAESTHESIA (Then her back went numb, with a lump/a numb feeling in the right side of my spine) and MUSCULOSKELETAL DISCOMFORT (pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine "). At the time of the report, PYREXIA (fever), ARTHRALGIA (joint pain), MYALGIA (muscle pain/aching all), FATIGUE (fatigue), URINARY INCONTINENCE (urinary incontinence/pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine "), FLANK PAIN (flank pain) and MUSCLE SPASMS (a weird spasm in that area) had not resolved and HYPOAESTHESIA (Then her back went numb, with a lump/a numb feeling in the right side of my spine) and MUSCULOSKELETAL DISCOMFORT (pain and incontinence had developed into a bubbling sensation in the last 3 inches of her lower spine ") outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Negative) Negative which found no stone and nothing remarkable.. On an unknown date, Computerised tomogram: which found no stone and nothing remarkable.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.